Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $64.4 billion.

  • Novartis Ag's Total Liabilities rose 1080.52% to $64.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $64.4 billion, marking a year-over-year increase of 1080.52%. This contributed to the annual value of $64.4 billion for FY2025, which is 1080.52% up from last year.
  • As of Q4 2025, Novartis Ag's Total Liabilities stood at $64.4 billion, which was up 1080.52% from $62.5 billion recorded in Q3 2025.
  • Novartis Ag's Total Liabilities' 5-year high stood at $74.5 billion during Q3 2023, with a 5-year trough of $53.2 billion in Q4 2023.
  • Over the past 5 years, Novartis Ag's median Total Liabilities value was $60.8 billion (recorded in 2023), while the average stood at $61.7 billion.
  • In the last 5 years, Novartis Ag's Total Liabilities soared by 2933.33% in 2023 and then crashed by 1929.97% in 2024.
  • Novartis Ag's Total Liabilities (Quarter) stood at $64.0 billion in 2021, then dropped by 9.29% to $58.0 billion in 2022, then fell by 8.33% to $53.2 billion in 2023, then rose by 9.26% to $58.1 billion in 2024, then increased by 10.81% to $64.4 billion in 2025.
  • Its last three reported values are $64.4 billion in Q4 2025, $62.5 billion for Q3 2025, and $62.3 billion during Q2 2025.